Blackstone Clarus III L.L.C.'s Net Worth
$358 Million
Who is Blackstone Clarus III L.L.C.?
Blackstone Clarus III L.L.C. has an estimated net worth of $358 Million. This is based on reported shares across multiple companies, which include Imago BioSciences, Inc., Talaris Therapeutics, Inc., Praxis Precision Medicines, Inc., ESSA Pharma Inc., GRAYBUG VISION, INC., Annexon, Inc., Forty Seven, Inc., Entasis Therapeutics Holdings Inc., and AVROBIO, Inc..
SEC CIK
Blackstone Clarus III L.L.C.'s CIK is 0001762202
Past Insider Trading and Trends
2021 was Blackstone Clarus III L.L.C.'s most active year for acquiring shares with 24 total transactions. Blackstone Clarus III L.L.C.'s most active month to acquire stocks was the month of April. 2021 was Blackstone Clarus III L.L.C.'s most active year for disposing of shares, totalling 16 transactions. Blackstone Clarus III L.L.C.'s most active month to dispose stocks was the month of April. 2020 saw Blackstone Clarus III L.L.C. paying a total of $7,400,000.00 for 12,461,583 shares, this is the most they've acquired in one year. In 2021 Blackstone Clarus III L.L.C. cashed out on 46,342,428 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Imago BioSciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.63% | -1.00M |
—
|
—
| 2.38M |
Mar 30
| |||
Form 4
|
∞
| 3.38M |
$16.00 |
—
| 3.38M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Talaris Therapeutics, Inc. (TRML) Snapshot price: $35.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +75.24% | 8.09M |
$17.00 | $510,000.00 | 18.84M |
May 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Praxis Precision Medicines, Inc. (PRAX) Snapshot price: $44.37
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +95.95% | 7.8M |
—
|
—
| 15.93M |
Oct 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ESSA Pharma Inc. (EPIX) Snapshot price: $11.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GRAYBUG VISION, INC. (CALC) Snapshot price: $5.6772
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.93M |
$16.00 |
—
| 1.93M |
Sep 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |